NCT06356415View on ClinicalTrials.gov

Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

September 30, 2024

Conditions
Upper Extremity Injury
Interventions
DRUG

Bupivacaine injection

Group one will receive infraclavicular block using bupivacaine

DRUG

Bupivacaine+ Dexamethasone+ Dexmedetomidine

Group two will receive infraclavicular block using dexamethasone and dexmedetomidine added to the bupivacaine

All Listed Sponsors
lead

Suez Canal University

OTHER

NCT06356415 - Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone | Biotech Hunter | Biotech Hunter